Congratulations to Dr. Robert Potter, Microbiology Fellow, co-recipient of the @WUSTLmed Laboratory and Genomic Medicine (LGM) award for delivering the outstanding trainee talk of the year for LGM Grand Rounds! Congratulations to Dr. Saravanan Raju, Clinical Pathology Resident, co-recipient of the @WUSTLmed Laboratory and Genomic Medicine (LGM) award for delivering the outstanding trainee talk of […]
Jeffrey I. Gordon, MD, the Dr. Robert J. Glaser Distinguished University Professor at Washington University School of Medicine in St. Louis, is a recipient of this year’s Balzan Prize for his role in founding the field of human gut microbiome research and revolutionizing the understanding of gut microbes and their roles in human health and disease.
COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.
Recently, the History of Clinical Chemistry Division of the AACC recognized Ann Gronowski, PhD for her efforts to promote the heritage of clinical chemistry by presenting her with the Caraway-Meites Award. This award recognizes individuals whose efforts have documented and described the origins, development, and impact of clinical chemistry on the practice of medicine. In the February […]
The virus that causes COVID-19 today is not the same as the one that first sickened people way back in December 2019. Many of the variants circulating now are partially resistant to some of the antibody-based therapeutics that were developed based on the original virus. As the pandemic continues, more variants inevitably will arise, and […]
Alphaviruses — mosquito-borne viruses that can trigger brain infections and arthritis — may have met their match. Researchers at Washington University School of Medicine in St. Louis have identified two antibodies that protect animals from disease caused by alphaviruses. The antibodies worked for every alphavirus tested, meaning they potentially could form the basis of treatments […]
Despite causing a surge in infections this summer that has resulted in thousands of hospitalizations and deaths, the delta variant of the virus that causes COVID-19 is not particularly good at evading the antibodies generated by vaccination, according to a study by researchers at Washington University School of Medicine in St. Louis.
The body’s so-called good cholesterol maybe even better than we realize. New research from Washington University School of Medicine in St. Louis suggests that one type of high-density lipoprotein (HDL) has a previously unknown role in protecting the liver from injury. This HDL protects the liver by blocking inflammatory signals produced by common gut bacteria.